2016_Head & Neck COURSE BOOK

Salivary duct carcinoma • Adenocarcinoma/salivary duct: rare • Higher prevalence in men, > 50 years old • Mainly in parotid gland • Agressive with median survival: 3 years • Histologically resemblance to invasive ductal carcinoma • ER and PR rarely positive • Androgen receptor present in 30-40% Salivary gland: metastatic disease